融券方面，港通医疗2月4日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元，超过近一年60%分位水平，处于较高位。 资料显示，四川港通医疗设备集团股份有限公司位于四川省成都市简阳市凯力威工业大道南段356号， 成立日期1998年1月13日，上市日期2023年7月25日，公司主营业务涉及为医疗机构提供以医用气体系统 及医院洁净手术部为核心的医疗专业工程整体方案。主营业务收入构成为：医用洁净装备及系统 55.69%，医用气体装备及系统37.30%，医疗设备及其他产品销售4.06%，运维服务2.81%，其他(补 充)0.14%。 来源：新浪证券-红岸工作室 2月4日，港通医疗涨0.67%，成交额7357.36万元。两融数据显示，当日港通医疗获融资买入额513.41万 元，融资偿还700.28万元，融资净买入-186.87万元。截至2月4日，港通医疗融资融券余额合计1.47亿 元。 融资方面，港通医疗当日融资买入513.41万元。当前融资余额1.47亿元，占流通市值的8.29%，融资余 额超过近一年90%分位水平，处于高位。 截至1月30日，港通医 ...

Core Viewpoint - The report indicates that 港通医疗 (Sichuan Porton Medical Equipment Group Co., Ltd.) is facing a projected loss for the year 2025, marking a significant shift from profit to loss, alongside delays in some fundraising projects due to external factors [1] Group 1: Stock Performance - As of February 3, 2026, 港通医疗's stock closed at 25.21 yuan, reflecting a 4.0% increase from the previous trading day [1] - The stock opened at 24.76 yuan, reached a high of 25.47 yuan, and a low of 24.22 yuan, with a trading volume of 73.46 million yuan and a turnover rate of 4.51% [1] Group 2: Regulatory Compliance - The report from 中信建投证券 (CITIC Securities) regarding the 2025 annual continuous supervision inspection indicates that the company is generally compliant in areas such as corporate governance, internal control, information disclosure, and use of raised funds [1] - However, the company is expected to incur a loss between 2 million to 4 million yuan for the year 2025, which is a reversal from previous profits [1] - Some fundraising projects are experiencing slower construction progress than anticipated, leading to the execution of delay procedures and subsequent announcements [1]

Core Viewpoint - The company, Sichuan Portong Medical Equipment Group Co., Ltd., specializes in medical gas equipment and cleanroom systems, with a focus on the development, design, manufacturing, integration, and operation services of these systems [3]. Business Overview - The main business of the company includes medical gas equipment and systems (55.69% of revenue), cleanroom equipment and systems (37.30%), sales of medical devices and other products (4.06%), operation services (2.81%), and other supplementary services (0.14%) [8]. - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title in China for small and medium-sized enterprises that excel in niche markets and possess strong innovation capabilities [3]. Recent Developments - The company has developed the Portong Cloud Monitoring Platform, which utilizes advanced IoT technology to provide real-time monitoring solutions for medical equipment in hospitals [2]. - As of January 30, the number of shareholders in Portong Medical was 9,164, a decrease of 4.48% from the previous period, while the average number of circulating shares per person increased by 4.69% [8]. Financial Performance - For the period from January to September 2025, the company reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to the parent company of -10.21 million yuan, a year-on-year decrease of 150.92% [8]. - The company has distributed a total of 48.9973 million yuan in dividends since its A-share listing [9]. Market Activity - On February 3, the stock price of Portong Medical increased by 4.00%, with a trading volume of 73.4646 million yuan and a turnover rate of 4.51%, bringing the total market capitalization to 2.521 billion yuan [1]. - The stock has experienced a net outflow of 1.1368 million yuan from major investors, indicating a reduction in holdings over the past three days [4][5].

中信建投证券股份有限公司 关于四川港通医疗设备集团股份有限公司 2025 年度持续督导定期现场检查报告 | 保荐人名称：中信建投证券股份有限公司 | 上市公司简称：港通医疗 | | | --- | --- | --- | | 保荐代表人姓名：李普海 | 联系电话：028-68850835 | | | 保荐代表人姓名：蒲飞 | 联系电话：028-68850835 | | | 现场检查人员姓名：李普海、蒲飞 | | | | 年度 现场检查对应期间：2025 | | | | 现场检查时间：2026 年 月 日 1 21 | | | | 一、现场检查事项 | 现场检查意见 | | | （一）公司治理 否 | 是 | 不适用 | | 现场检查手段：查看公司生产经营场所，查阅公司章程、公司治理相关规章制度、三会文件 | | | | 以及信息披露文件等，并与管理层沟通或访谈 | | | | 1.公司章程和公司治理制度是否完备、合规 | 是 | | | 2.公司章程和股东会、董事会规则是否得到有效执行 | 是 | | | 3.股东会、董事会会议记录是否完整，时间、地点、出席 | 是 | | | 人员及会议内容等要件是否齐备， ...

证券日报网讯 2月3日，港通医疗在互动平台回答投资者提问时表示，公司截至2026年1月30日股东总户 数为9164户。 （文章来源：证券日报） ...

Core Viewpoint - The medical device sector experienced a rise of 1.42% on February 3, with Huakang Clean leading the gains, while the overall market indices also showed positive performance [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4067.74, up by 1.29% [1]. - The Shenzhen Component Index closed at 14127.1, up by 2.19% [1]. Group 2: Top Gainers in Medical Device Sector - Huakang Clean (301235) closed at 53.83, with a gain of 9.86% and a trading volume of 114,200 shares, amounting to a transaction value of 610 million yuan [1]. - Baocait (300246) closed at 13.15, up by 7.96% with a trading volume of 178,500 shares, totaling 229 million yuan [1]. - Yirui Technology (688301) closed at 119.24, increasing by 7.10% with a trading volume of 41,000 shares, resulting in a transaction value of 477 million yuan [1]. - Hualan Co. (301093) closed at 86.08, up by 6.45% with a trading volume of 60,900 shares, totaling 482 million yuan [1]. - Tianzhihang (688277) closed at 24.18, increasing by 6.10% with a trading volume of 159,300 shares, amounting to 379 million yuan [1]. Group 3: Market Outflows and Inflows - The medical device sector saw a net outflow of 253 million yuan from institutional investors and a net outflow of 112 million yuan from speculative funds, while retail investors had a net inflow of 365 million yuan [2]. - The detailed fund flow for individual stocks indicates varying levels of net inflow and outflow among different companies [3].

证券之星消息，港通医疗(301515)02月02日在投资者关系平台上答复投资者关心的问题。 投资者提问：请问1月31日公司股东人数是多少？谢谢！ 港通医疗回复：尊敬的投资者，您好！公司截至2026年1月30日股东总户数为9164户，感谢您的关注。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

来源：新浪证券-红岸工作室 资料显示，四川港通医疗设备集团股份有限公司位于四川省成都市简阳市凯力威工业大道南段356号， 成立日期1998年1月13日，上市日期2023年7月25日，公司主营业务涉及为医疗机构提供以医用气体系统 及医院洁净手术部为核心的医疗专业工程整体方案。主营业务收入构成为：医用洁净装备及系统 55.69%，医用气体装备及系统37.30%，医疗设备及其他产品销售4.06%，运维服务2.81%，其他(补 充)0.14%。 截至1月20日，港通医疗股东户数9594.00，较上期减少17.81%；人均流通股6834股，较上期增加 21.67%。2025年1月-9月，港通医疗实现营业收入3.44亿元，同比减少30.06%；归母净利润-1020.84万 元，同比减少150.92%。 融资方面，港通医疗当日融资买入279.63万元。当前融资余额1.42亿元，占流通市值的8.48%，融资余 额超过近一年90%分位水平，处于高位。 融券方面，港通医疗1月30日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元，超过近一年60%分位水平，处于 ...

截至2026年1月29日收盘，港通医疗(301515)报收于23.8元，下跌1.29%，换手率4.16%，成交量2.73万 手，成交额6581.84万元。 当日关注点 交易信息汇总 资金流向 1月29日主力资金净流出707.58万元；游资资金净流入295.5万元；散户资金净流入412.08万元。 四川港通医疗设备集团股份有限公司预计2025年度归属于上市公司股东的净利润亏损200.00万元至 400.00万元，上年同期为盈利1,442.19万元。扣除非经常性损益后的净利润亏损600.00万元至1,000.00万 元，上年同期盈利500.84万元。业绩变动主要原因包括合同执行进度不及预期导致营业收入下降，应收 账款增加致减值准备计提上升，理财收益下降及新投资子公司费用增加导致期间费用上升。公司已与会 计师事务所就业绩预告进行预沟通，无分歧。最终数据以2025年年度报告为准。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：1月29日主力资金净流出707.58万元，散户资金净流入412.08万元。 来自业绩披露要点：港 ...

截至2026年1月29日收盘，港通医疗（301515）报收于23.8元，较前一交易日下跌1.29%，最新总市值为 23.8亿元。该股当日开盘24.1元，最高24.6元，最低23.65元，成交额达6581.84万元，换手率为4.16%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 公司于近日披露《2025年度业绩预告》。公告显示，四川港通医疗设备集团股份有限公司预计2025年度 归属于上市公司股东的净利润亏损200.00万元至400.00万元，上年同期为盈利1,442.19万元；扣除非经常 性损益后的净利润亏损600.00万元至1,000.00万元，上年同期盈利500.84万元。业绩变动主要原因包括合 同执行进度不及预期导致营业收入下降，应收账款增加致减值准备计提上升，理财收益下降及新投资子 公司费用增加导致期间费用上升。公司已与会计师事务所就业绩预告进行预沟通，无分歧。最终数据以 2025年年度报告为准。 《2025年度业绩预告》 最新公告列表 ...